IL255697B2

Compositions and methods for tcr reprogramming using fusion proteins

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

Every citation, both waysCites: the store holds 3 of 4

Citations
DocumentRelationOfficeCategoryCited duringRelevant claims
EP0638119A1CitesEuropean Patent Office (EPO)–Search report–
WO2010052014A1CitesWorld Intellectual Property Organization (WIPO)–Search report–
EP2258720A1CitesEuropean Patent Office (EPO)XSearch report2-50
NOLAN, K. F., ET AL., BYPASSING IMMUNIZATION: OPTIMIZED DESIGN OF “DESIGNER T CELLS” AGAINST CARCINOEMBRYONIC ANTIGEN (CEA)-EXPRESSING TUMORS, AND LACK OF SUPPRESSION BY SOLUBLE CEA., 31 December 1999 (1999-12-31)Non-patent––Search report–